Clinical Trials Directory

Trials / Completed

CompletedNCT05666245

DMID 21-0041; Influenza CVD 59000

Evaluating Modes of Influenza Transmission Through the Conduct of Controlled Human Influenza Virus Infection Transmission Trials (CHIVITTs)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

The primary objective of EMIT-2 is to use a randomized controlled trial (RCT) design to implement interventions which are known to reduce inhalation (airborne) transmission, so that the contribution of transmission by route of aerosols for influenza may be identified.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPersonal Protective Equipment (PPE) - Under High Air HygieneIntervention Recipients (IRs) will be required to wear a lightweight plastic face shield, comply with hand hygiene (i.e., using a hand sanitization product every 15 minutes, plus periodic hand washing with soap and water), and avoid face touching during each planned exposure event. The face shield may only be removed after leaving the exposure room to go to the bathroom, for other short comfort breaks, and at mealtimes. In these instances, hand hygiene will be used after removing or replacing the face shield; and Donors will not be present. Hand washing with soap and water will be required before meals. IR will be separated from Donors by more than 6 feet during meals. The exposure room will be supervised by a trained member of the study staff who will monitor to ensure that Intervention Recipients wear the face shield continuously, are separated from Donors at meals, and do not touch their faces. High air hygiene is achieved by filtration and/or use of germicidal UV-C.
BEHAVIORALNo Intervention - Under High Air HygieneNo intervention High air hygiene is achieved by filtration and/or use of germicidal UV-C.
BEHAVIORALPersonal Protective Equipment (PPE) - Under Low Air HygieneIntervention Recipients (IRs) will be required to wear a lightweight plastic face shield, comply with hand hygiene (i.e., using a hand sanitization product every 15 minutes, plus periodic hand washing with soap and water), and avoid face touching during each planned exposure event. The face shield may only be removed after leaving the exposure room to go to the bathroom, for other short comfort breaks, and at mealtimes. In these instances, hand hygiene will be used after removing or replacing the face shield; and Donors will not be present. Hand washing with soap and water will be required before meals. IR will be separated from Donors by more than 6 feet during meals. The exposure room will be supervised by a trained member of the study staff who will monitor to ensure that Intervention Recipients wear the face shield continuously, are separated from Donors at meals, and do not touch their faces. Low air hygiene is achieved with minimal ventilation.
BEHAVIORALNo Intervention - Under Low Air HygieneNo intervention Low air hygiene is achieved with minimal ventilation.

Timeline

Start date
2023-02-20
Primary completion
2024-04-17
Completion
2024-04-17
First posted
2022-12-27
Last updated
2025-08-26
Results posted
2025-08-26

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05666245. Inclusion in this directory is not an endorsement.

DMID 21-0041; Influenza CVD 59000 (NCT05666245) · Clinical Trials Directory